- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06123741
Virtual Reality in Rehabilitation of Executive Functions in Children With Attention Deficit Hyperactivity Disorder. (VREALFUN-ADHD)
Virtual Reality in Rehabilitation of Executive Functions in Children (VREALFUN)
Attention deficit hyperactivity disorder (ADHD) is caused by an abnormality in the development of the central nervous system. Children with attention and executive function difficulties often need long-lasting rehabilitation and there is an increasing need for timely, cost-effective, and feasible rehabilitation interventions, where the training is targeted to support everyday life functional capacity. The use of Virtual Reality (VR) in the rehabilitation of children with attention and executive function deficits offers opportunities to practice skills required in everyday life in environments emulating real-life situations.
The major aim of this research project is to develop a novel effective VR rehabilitation method for children with deficits in attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday life. In this randomized control study VR glasses are used to present the tasks, and the levels of difficulty are adjusted according to the child's progress.
Researchers expect that; 1) Intensive training improves the attention regulation, activity control skills and executive functions of the children in the intervention group; 2) Training of executive skills with motivating tasks in a virtual environment that is built to meet challenging everyday situations transfers to the child's everyday life, 3) The duration of the training effect does not depend on the success of the VR training itself, but on how well the child adopts new strategies that make everyday life easier and how the parent is able to support the child's positive behaviour in everyday life.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Merja Nikula, M.Psych.
- Phone Number: +3588315 5218
- Email: merja.nikula@pohde.fi
Study Contact Backup
- Name: Johanna Uusimaa, MD, PhD
- Email: johanna.uusimaa@pohde.fi
Study Locations
-
-
-
Oulu, Finland, 90029
- Recruiting
- Oulu University Hospital
-
Contact:
- Johanna Uusimaa, MD, PhD
- Email: johanna.uusimaa@pohde.fi
-
Contact:
- Merja Nikula, M.Psych.
- Email: merja.nikula@pohde.fi
-
Principal Investigator:
- Merja Nikula, M.Psych.
-
Sub-Investigator:
- Johanna Uusimaa, MD, PhD
-
Sub-Investigator:
- Mirjami Mäntymaa, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of ADHD (ICD-10 F90.0) and
- Methylphenidate medication and
- Age 8-12 years and
- Finnish as a native language
Exclusion Criteria:
- Sensitivity to flashing light,
- Epilepsy (ICD-10 G40),
- Mental retardation (ICD-10 F70-F79),
- Pervasive developmental disorders (ICD-10 F84),
- Inflammatory diseases of the central nervous system (ICD-10 G00-G09),
- Severe cerebral palsy syndrome (ICD-10 G80, GMFCS 4-5, MACS 3-5),
- Traumatic brain injury ((ICD-10 S06),
- Brain tumour, and
- Multiple pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Parental Guidance+Virtual Reality Game
|
Parents get guidance for children's positive behaviour support by using parts of Self-Help Program on the MentalHub.fi
(in Finnish: Mielenterveystalo.fi) website regarding children's challenging behaviour (in Finnish: Lasten haastavan käytöksen omahoito-ohjelma) .
Other Names:
Virtual reality game for rehabilitation of attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday situations at home.
|
|
Experimental: Parental Guidance
|
Parents get guidance for children's positive behaviour support by using parts of Self-Help Program on the MentalHub.fi
(in Finnish: Mielenterveystalo.fi) website regarding children's challenging behaviour (in Finnish: Lasten haastavan käytöksen omahoito-ohjelma) .
Other Names:
|
|
Experimental: Virtual Reality Game
|
Virtual reality game for rehabilitation of attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday situations at home.
|
|
No Intervention: Control Group
This group implement the rehabilitation plan drawn up in specialized medical care (treatment as usual).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Epeli (Executive Performance in Everyday LIving) task
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
A virtual reality task for attention, executive function, and prospective memory.
Change in total score, task efficacy, navigation efficacy, controller motion, and total action.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
ADHD-rating scale IV (ADHD-RS) (parent report)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
The ADHD-RS (parent report) is an assessment of a child's ADHD symptoms with 18 items based on the child's behaviour over the past 6 months.
4-point Likert scale.
The total score ranges 0-54, scores in inattention subscale and hyperactivity/impulsivity subscale range 0-27.
Change in the total score, inattention subscale score, and hyperactivity/impulsivity subscale score on a parent-rated ADHD-RS.
A lower score means a better outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Epeli Questionnaire (parent report)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks.
5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20.
Change in Functional ability subscale score and Positive feedback subscale score on parent-rated Epeli- questionnaire.
A higher score means a better outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Epeli Questionnaire (child report)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks.
5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20.
Change in Functional ability subscale score and Positive feedback subscale score on child-rated Epeli- questionnaire.
A higher score means a better outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavior Rating Inventory of Executive Function (BRIEF-2) (parent form)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
A measure of executive functions of children and adolescents in natural settings containing 63 items rated by the parent.
3-point Likert scale.
Change in Global Executive Composite score, Behavior regulation score, Emotion regulation score, and Cognitive regulation score on parent-rated BRIEF-2.
In case the data in the Behavior regulation, Emotion regulation, and Cognitive regulation subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on the BRIEF-2 Global Executive Composite score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected.
A higher score means a worse outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Behavior Rating Inventory of Executive Function (BRIEF-2) (teacher form)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
A measure of executive functions of children and adolescents in natural settings containing 63 items rated by the teacher.
3-point Likert scale.
Change in Global Executive Composite score, Behavior regulation score, Emotion regulation score, and Cognitive regulation score on teacher-rated BRIEF-2.
In case the data in the Behavior regulation, Emotion regulation, and Cognitive regulation subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on the BRIEF-2 Global Executive Composite score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected.
A higher score means a worse outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Concentration questionnaire (in Finnish: Keskittymiskysely)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of attention and executive function difficulties in school-aged children with 55 items.
3-point Likert Scale, Total score range 0-110.
Change in Total score, Distractibility score (range 0-8), sum of Impulsivity and Motor hyperactivity subscales scores (range 0-32), sum of Directing, Sustaining and Shifting Attention subscales scores (range 0-30), and sum of Initiative, Planning, Execution and Evaluation of Action subscales scores (range 0-40) on teacher-rated Concentration questionnaire.
In case the data in the Distractibility subscale, Impulsivity and Motor hyperactivity subscales, Attention subscales and Executive subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on Concentration questionnaire Total score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected.
A higher score implies a worse outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version ( KINDL-R) (parent version)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of Health-Related Quality of Life in children and adolescents with 24 items.
5-point Likert scale.
Change in Total score on parent-rated questionnaire.
A higher score means a better outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version (KINDL-R) (self-report version)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of Health-Related Quality of Life in children and adolescents with 24 items.
5-point Likert scale.
Change in Total score on child-rated questionnaire.
A higher score means a better outcome.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
N-back test
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
A test for a working memory.
Change in 2-back and 1-back hitrate and reaction time.
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
The Conners Continuous Performance Test 3rd Edition (Conners CPT3)
Time Frame: Baseline, 4-6 weeks, 6 months and 12 months.
|
A computerized attention task validated in individuals aged 8 years and older.
Change in scores on Conners Continuous Performance Test (CPT-3).
|
Baseline, 4-6 weeks, 6 months and 12 months.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Johanna Uusimaa, MD, PhD, Oulu University Hospital
- Principal Investigator: Merja Nikula, M.Psych., Oulu University Hospital
- Study Director: Mirjami Mäntymaa, MD, PhD, Oulu University Hospital
- Study Director: Juha Salmitaival, PhD, University of Oulu, Finland
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 206/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH); Louisiana State University Health...Recruiting
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
Clinical Trials on Parental Guidance
-
Yale UniversityCompletedAnxiety Disorders | Failure to Launch | HikikomoriUnited States
-
Aurore LiénardJules Bordet Institute; Erasme University Hospital; Université Libre de Bruxelles and other collaboratorsCompletedParent-Child Relations | Parenting | Communication ProgramsBelgium
-
Universidade Federal de PernambucoCoordination for the Improvement of Higher Education PersonnelNot yet recruitingChild Development | Music Education | Early Child Development | Adaptive Behavior | Preschool EducationBrazil
-
Ankara Yildirim Beyazıt UniversityCompletedDental Caries | Dental Anxiety | Children, OnlyTurkey (Türkiye)
-
Merja NikulaHelsinki University Central Hospital; University of Helsinki; University of Oulu and other collaboratorsRecruiting
-
Tel Aviv UniversityCompleted
-
University Hospital Inselspital, BerneCompletedPreterm Infants | Parents | Procedural PainSwitzerland
-
University Hospital, MontpellierCompletedInfant DevelopmentFrance
-
Izmir Katip Celebi UniversityDr. Behcet Uz Children's HospitalNot yet recruitingParent | Comfort | Family Centered Care | Vital Sign Evaluation
-
Université Catholique de LouvainSuspendedDeaf Nonspeaking, Not Elsewhere ClassifiedBelgium